Cargando…
Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide
BACKGROUND/AIMS: Veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) is one of the most fatal complications of hematopoietic cell transplantation (HCT), and defibrotide is the only curative drug. We conducted this study to confirm the survival rate of VOD/SOS patients diagnosed in Korea...
Autores principales: | Kong, Seom Gim, Lee, Je-Hwan, Lim, Young Tak, Lee, Ji Hyun, Eom, Hyeon-Seok, Lee, Hyewon, Kim, Do Young, Lim, Sung-Nam, Yoon, Sung-Soo, Kim, Sung-Yong, Lee, Ho Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747908/ https://www.ncbi.nlm.nih.gov/pubmed/34902236 http://dx.doi.org/10.3904/kjim.2021.178 |
Ejemplares similares
-
Defibrotide for hepatic veno-occlusive disease
Publicado: (2021) -
Defibrotide in the treatment of hepatic veno-occlusive disease
por: Fulgenzi, Alessandro, et al.
Publicado: (2016) -
Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report
por: Lee, Tae Beom, et al.
Publicado: (2021) -
T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia
por: Kim, Hyerim, et al.
Publicado: (2019) -
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant
por: Nauffal, Mary, et al.
Publicado: (2022)